Skip to main content
. 2022 Apr 7;13:851967. doi: 10.3389/fendo.2022.851967

Table 2.

Demographic data and disease characteristics of the study groups.

Control vs. All Patients DM vs. DR Control vs. DR NPDR vs. PDR
Variables Control All Patients p OR (95% CI) DM DR p OR (95% CI) p OR (95% CI) NPDR PDR p OR (95% CI)
Number 11 59 10 49 26 23
Age
Mean ± SD 62.9 ± 17.29 64.2 ± 11.49 0.52 70.7 ± 7.13 62.9 ± 11.75 0.9 0.62 65.6 ± 11.16 59.7 ± 11.63 0.9
 ≤ 50 3 (27.3) 5 (8.5) 0.07 Reference 0 (0) 5 (10.2) 0.29 Reference 0.13 Reference 1 (3.8) 4 (17.4) 0.12 Reference
 > 50 8 (72.7) 54 (91.5) 4.05 (0.81-20.31) 10 (100) 44 (89.8) 0 3.3 (0.65-16.63) 25 (96.2) 19 (82.6) 0.19 (0.02-1.84)
Sex
 Female 7 (63.6) 15 (25.4) 0.01 Reference 4 (40) 11 (22.4) 0.01 Reference 0.007 Reference 5 (19.2) 6 (26.1) 0.6 Reference
 Male 4 (36.4) 44 (74.6) 5.13 (1.32-20.02) 6 (60) 38 (77.6) 2.3 (0.55-9.64) 6.05 (1.49-24.51) 21 (80.8) 17 (73.9) 0.67 (0.18-2.6)
Other
 BMI (kg/m2) 29.3 ± 3.08 31.1 ± 6.29 0.24 NA 30.4 ± 4.53 31.2 ± 6.54 0.4 NA 0.25 NA 31.9 ± 5.56 30.5 ± 7.26 0.9 NA
 HbA1c (µmol/L) 5.6 ± 0.74 7.5 ± 2.63 < 0.001 NA 6.6 ± 1.12 7.7 ± 2.82 0.02 NA < 0.001 NA 6.9 ± 2.88 8.3 ± 2.6 0.06 NA
Creatinine 75.8 ± 21.58 95.5 ± 48.58 0.1 NA 82 ± 14.71 97.9 ± 52.07 0.25 NA 0.1 NA 101.3 ± 48.68 94.8 ± 54.79 0.8 NA

Data are represented as number (percentage) or mean ± standard deviation (SD). DM, diabetes mellitus patients without retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy. OR (95% CI), odds ratio and 95% confidence interval. Mann Whitney u test for quantitative variables and chi-square test for qualitative data were applied. Items in italics indicate p < 0.05. NA, not applicable.